Compugen
CGEN
#9043
Rank
โ‚ฌ0.15 B
Marketcap
1,68ย โ‚ฌ
Share price
-2.13%
Change (1 day)
20.96%
Change (1 year)

Earnings for Compugen (CGEN)

Earnings in 2026 (TTM): โ‚ฌ29.61 Million

According to Compugen's latest financial reports the company's current earnings are โ‚ฌ72.65 Million. In 2025 the company made an earning of โ‚ฌ32.26 Million, an increase over its 2024 earnings that were of -โ‚ฌ8.85 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Compugen from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚ฌ29.61 M-8.21%
2025 โ‚ฌ32.26 M-464.58%
2024 -โ‚ฌ8.85 Million-0.77%
2023 -โ‚ฌ8.92 Million-70.91%
2022 -โ‚ฌ30.66 Million-1.66%
2021 -โ‚ฌ31.18 Million15.17%
2020 -โ‚ฌ27.07 Million5.84%
2019 -โ‚ฌ25.58 Million24.16%
2018 -โ‚ฌ20.6 Million-39.03%
2017 -โ‚ฌ33.79 Million17.72%
2016 -โ‚ฌ28.7 Million59.22%
2015 -โ‚ฌ18.03 Million84.23%
2014 -โ‚ฌ9.79 Million-20.97%
2013 -โ‚ฌ12.38 Million-5.86%
2012 -โ‚ฌ13.15 Million20.44%
2011 -โ‚ฌ10.92 Million52.06%
2010 -โ‚ฌ7.19 Million3.26%
2009 -โ‚ฌ6.96 Million-37.67%
2008 -โ‚ฌ11.16 Million-3.37%
2007 -โ‚ฌ11.55 Million-8.64%
2006 -โ‚ฌ12.64 Million
2004 -โ‚ฌ14.2 Million9.57%
2003 -โ‚ฌ12.96 Million-5.5%
2002 -โ‚ฌ13.72 Million-20.9%
2001 -โ‚ฌ17.34 Million27.35%
2000 -โ‚ฌ13.62 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Seagen
SGEN
-โ‚ฌ0.73 Billion-2,366.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
-โ‚ฌ3.53 Million-111.08%๐Ÿ‡ฆ๐Ÿ‡บ Australia
Teva Pharmaceutical Industries
TEVA
โ‚ฌ1.11 B 3,408.87%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Eterna Therapeutics
ERNA
-โ‚ฌ15.06 Million-147.36%๐Ÿ‡บ๐Ÿ‡ธ USA